James Wilkie

Jim has 33 years of experience in the life science industry developing both drugs and devices. Prior to co-founding Lowell Therapeutics, he served as the VP of New Enterprise Development at La Jolla Pharmaceutical Company where he identified Niyad™ for development in the US market. Prior to working at La Jolla, Jim was the COO of Pluromed, Inc. where he led the development and commercialization of two successful products in the U.S. and Europe. The first product was licensed to Boston Scientific, which fueled the development of the flagship product. He was instrumental in the sale of the company to Sanofi, which provided a 6x return to seed investors and 4.7x to Series A. Jim was the head of Engineering for 3 sites at MedChem Products and helped sell the company to C.R. Bard after which he co-founded Surgical Sealants, Inc. in 1997. Jim holds 4 issued patents and several pending applications. He received a B.S. in Engineering from the University of Massachusetts in 1985.